| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
CH:LONN
Lonza Group Ltd
|
Sep 24, 2026 | BUY |
Strong Buy
+13.7% avg upside
21 analysts
|
$730.00
28.26% Upside
|
+0.0% | · |
|
FR:IPN
Ipsen
|
Sep 21, 2026 | SELL |
Hold
-12.1% avg upside
17 analysts
|
$155.00
8.22% Upside
|
+4.9% | · |
|
GB:0NZT
UCB SA
|
Sep 18, 2026 | HOLD |
Strong Buy
+4.0% avg upside
19 analysts
|
$260.00
21.17% Upside
|
· | · |
|
FR:DIM
Sartorius Stedim Biotech
|
Sep 08, 2026 | BUY |
Strong Buy
+20.0% avg upside
12 analysts
|
$240.00
13.03% Upside
|
+11.4% | · |
|
DE:MRK
Merck KGaA
|
Sep 08, 2026 | HOLD |
Buy
+2.5% avg upside
34 analysts
|
$150.00
11.06% Upside
|
+1.7% | · |
|
DE:BAYN
Bayer
|
Sep 08, 2026 | BUY |
Buy
+8.9% avg upside
31 analysts
|
$70.00
39.85% Upside
|
+1.5% | · |
|
GB:0MGB
Genmab A/S
|
Sep 08, 2026 | BUY |
Buy
-7.6% avg upside
25 analysts
|
$2900.00
27.24% Upside
|
· | · |
|
CH:PPGN
PolyPeptide Group AG
|
Sep 08, 2026 | HOLD |
Hold
-17.4% avg upside
3 analysts
|
$44.31
0.55% Upside
|
+0.2% | · |
|
CH:BANB
Bachem Holding AG
|
Sep 08, 2026 | HOLD |
Sell
-7.4% avg upside
4 analysts
|
$80.00
1.63% Downside
|
+5.0% | · |
|
FR:BIM
bioMerieux
|
Sep 07, 2026 | HOLD |
Hold
+26.1% avg upside
12 analysts
|
$80.00
2.86% Upside
|
+7.8% | · |
|
IT:DIA
DiaSorin S.p.A.
|
Sep 07, 2026 | SELL |
Sell
+38.8% avg upside
10 analysts
|
$70.00
11.19% Downside
|
-7.0% | · |
|
IT:REC
Recordati Industria Chimica e Farmaceutica SPA
|
Jul 30, 2026 | HOLD |
Buy
-2.5% avg upside
9 analysts
|
$50.00
5.70% Downside
|
+2.7% | · |
|
DE:SRT3
Sartorius
|
Apr 23, 2026 | BUY |
Strong Buy
+6.9% avg upside
19 analysts
|
$270.00
4.54% Upside
|
+19.0% | · |
|
ES:GRF
Grifols
|
Apr 22, 2026 | BUY |
Hold
+50.8% avg upside
13 analysts
|
$12.50
30.27% Upside
|
+8.2% | · |
|
CH:SDZ
Sandoz Group Ltd
|
Mar 11, 2026 | HOLD |
Buy
-4.5% avg upside
12 analysts
|
$75.00
5.50% Upside
|
+16.9% | · |
|
BAYRY
Bayer
|
Jan 06, 2026 | BUY |
Buy
+189.2% avg upside
9 analysts
|
— | +27.0% | · |
|
GB:DIA
Dialight
|
Jan 06, 2026 | SELL |
Strong Sell
1 analyst
|
— | -63.1% | · |
|
GB:0QW0
arGEN X
|
Oct 31, 2025 | BUY |
Strong Buy
-25.2% avg upside
25 analysts
|
$850.00
1.03% Upside
|
· | · |
|
ARGX
Argenx Se
|
Apr 28, 2025 | BUY |
Strong Buy
-13.5% avg upside
48 analysts
|
$740.39
22.81% Downside
|
+24.8% | · |
|
GRFS
Grifols SA
|
Jan 04, 2024 | BUY |
Buy
+224.8% avg upside
13 analysts
|
$20.50
178.87% Upside
|
-32.1% | · |
|
ABBV
AbbVie
|
Jan 13, 2022 | BUY |
Strong Buy
-7.9% avg upside
47 analysts
|
— | +19.4% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.